Capgemini stock jumps 4% on buzz that Infosys may pick up a stake, no comments says Infy

Shares of Europe’s largest it services group, Capgemini, soared in the French stock markets - it surged nearly 4% to a 2-week high of Euro 53.19 per share, on buzz that Infosys Technologies could be interested in bidding for it.

The day's surge has made it the biggest gainer on France’s CAC-40 benchmark index. Both Infosys and Capgemini have refused to comment on the rumours. The Infosys stock closed Rs 10 lower at Rs 1,925 per share.

Ramesh Damani, Member BSE said I do not expect Infy to takeover Capgemini; there could be some of sort partnership. There could be a tie up for the BPO arm between Capgemini & Infosys. Window of opportunity for Infosys has passed. It is too big a deal to bite off for Infosys. Infosys will not look at diluting equity at this point of time.

Handling Rupee rise will be a huge challenge for IT companies. Indian tech companies will have to look for other markets to hedge against appreciating Rupee. Large tech companies will face margin pressure in next 2 years, Damani added.

"I think with reflection of time the window of opportunity is already been closed down. If you just look at the deal right now, Capgemini is a company that was at one time sale 5% margin; Infosys goes at 8 times sales almost more than 30% margin. Infosys now has huge challenges; recruiting in terms of its staff, in terms of maintaining its margins because the rupee has been appreciating so strongly. My sense is that that window that was open to them has passed. Infosys consistently said that they are looking more for cultural fits, more for niche businesses. I do not think it meets that criteria. If we were to speculate, I think it could be a tie-up between Capgemini and Infosys for their BPO arm that would make more sense because that is a fast growth area and an area where both could help each other," Damani mentioned.




Bonus bonanza boosts Banco Products

The announcement was made after market hours on Thursday, 28 June 2007.

The scrip had touched a high of Rs 342 and a low of Rs 315.10 during the day and closed at 317.40.

The stock had an average daily volume of 4,035 shares on BSE in the past one quarter.

At the current price of Rs 334.90, the scrip trades at a PE multiple of 8.96 based on year ended March 2007 EPS of Rs 37.37.

The Banco Products scrip gained 19.46% in the one month to 28 June 2007 versus the Sensex's 0.65% rise. It had added 28.45% in the past three months against the Sensex's 10.96% rise.

The stock had hit a 52-week high of 347.45 on 26 June 2007 and a 52-week low of Rs 144 on 28 June 2006.

Banco Products’ net profit surged 60.1% to Rs 6.21 crore in Q4 March 2007 as against Rs 3.88 crore in Q4 March 2006. Sales moved up 57.8% to Rs 74.35 crore in Q4 March 2007 (Rs 47.11 crore).

Net profit scaled up 98.7% to Rs 25.26 crore in the year ended March 2007 as against Rs 12.71 crore in FY 2006. Sales jumped 50.7% to Rs 260.21 crore in FY 2007 (Rs 172.68 crore).

Banco Products operates in the gasket and radiator segments. Its products find wide applications in automobiles, oil engines, compressors, locomotives, and machinery.





HDFC in talks to partner Travelers of the US for its general insurance

HDFC seems to have found a new partner for its general insurance business. And it could be one of the largest insurance companies in the US. It is learnt that HDFC is eyeing US-based Travelers as JV partner. HDFC is believed to be in advanced talks with Travelers. The said JV would focus on general insurance business. Travelers eyes 26% stake in HDFC's general insurance business.

Travelers had FY06 revenues at $ 25 billion. It is the 2nd largest writer of US property and personal insurance. It has over 7 million personal insurance policies in force.

HDFC bought out JV partner Chubb's 26% stake for Chubb General Insurance business. Its gross premium underwritten for FY07 was Rs 190 crore.




India's biggest bank talks business – SBI sees $ 7 Bn in its insurance business & gets ready to unlock value

The country's largest bank has chalked out a roadmap for the next 3-4 years. First on the State Bank of India’s agenda is capital raising and then forming a holding company for its asset management and insurance businesses. State Bank of India Chairman OP Bhatt's main agenda these days is to find capital for its various businesses.

The bank is in the process of forming a NBFC, which will be a holding company for its stakes in SBI life insurance and SBI mutual fund. The bank has already started approaching strategic inventors who may want to buy into this holding company and looks like he will be able to command a tall price.

OP Bhatt said, “State Bank of India is the only insurance company in the private sector. we are talking to, are in the range of about $ 7 billion.”

SBI also talking to domestic and international players for its foray into general insurance and pension fund business, and these companies should be afloat by the year end. The bank is gearing up for the launch of its wealth management business and plans to recruit over 1000 relationship managers for this business.

So where is the capital going to come from? The bank is meeting with investment bankers for a follow on public issue by the year-end. SBI is hoping the SBI Act will be amended in July to allow the Govt stake to fall to 5%. In that case it can raise Rs 15,000 crore of capital in one tranche. And this how the capital will be deployed.

Bhatt further said, “The capital will be deployed against current asset growth...whatever provisions have to be made for AS 15, we will be making those provisions also.”

SBI is not clear about when its 3 associate banks will list or if and when they will merge with the parent. SBI's management is also getting aggressive on regaining its market share... it has set targets of increasing its market share in advances and deposits by 1% every year.




Glenmark Pharmaceuticals purrs as US FDA okays copycat drug

The scrip had touched a high of Rs 668 and a low of Rs 648.10 during the day and closed at 658.70. It touched a 52-week high of Rs 735 on 4 June 2007 and a 52-week low of Rs 265.50 on 28 June 2006.

On BSE, 1.14 lakh shares were traded on the counter. The average daily volume in the stock was 2.03 lakh shares on BSE in the past one quarter.

The Glenmark Pharmaceuticals scrip had declined from Rs 680.60 on 15 June 2007 to Rs 650.70 on 28 June 2007.

The stock slipped 3.34% in the past one month to 28 June 2007 versus the Sensex's 0.65% rise. It had underperformed the market in the past three months, rising 6.71% as against the Sensex's 10.96% appreciation.

The current price of Rs 430.50 discounts its FY 2007 EPS of Rs 25.9 (based on consolidated results) by a PE multiple of 16.62.

Glenmark Pharmaceuticals announced during market hours today, 29 June 2007, that it had received final approval from the US Food and Drug Administration for its abbreviated new drug applications (ANDAs) for ondansetron hydrochloride (HCI) tablets 4 mili gram (mg), 8 mg and 24 mg and ondansetron orally disintegrating tablets of 4 mg and 8 mg.

Ondansetron HCI tablets are the generic version of GlaxoSmithKline's Zofran(R) tablets. The tablets had US sales of approximately $744 million for the same strengths in the 12-month period ended 31 March 2007.

On 16 May 2007, Glenmark Pharmaceuticals received US FDA’s approval to market Pravastatin sodium oral tablets in the US. Pravastatin is a generic version of the Bristol Myers Squibb brand, Pravachol.

In April 2007, the company had received approval to market a generic version of Roche's Anaprox and Naprosyn.

On 29 March 2007, Schering Corporation and MSP Singapore Company had together filed a legal suit against the Indian drug maker to disallow it from marketing a copy-cat version of Ezetimibe.

Glenmark Pharmaceuticals' net profit surged 149.5% to Rs 62.56 crore in Q4 March 2007, from Rs 25.07 crore in Q4 March 2006. Sales jumped 72.8% to Rs 274.79 crore in Q4 March 2007 (Rs 159.01 crore).

Net profit soared 100.3% to Rs 134.80 crore in the year ended 31 March 2007 (FY 2007) as against Rs 67.30 crore in FY 2006. Sales moved up 44.3% to Rs 802.64 crore in FY 2007 (Rs 556.09 crore).

On 11 June 2007, the board of Glenmark Pharmaceuticals had approved the sub-division of the equity shares of the company from Rs 2 per share to Re 1 per share.

Glenmark Pharmaceuticals manufactures and sells pharmaceutical ingredients. The group also operates a research facility at Sinnar, Nashik for developing formulations for India and markets across Africa, Asia, Latin America and CIS/Russia.





C & C Constructions turns north on new order

The scrip had touched a high of Rs 214 and a low of Rs 200.15 during the day and closed at 211.00. On BSE, 1.75 lakh shares of the scrip were traded.

The stock had an average daily volume of 81,195 shares on BSE in the past one quarter.

At the current price of Rs 209.60, the scrip trades at a PE multiple of 11.63, based on its Q3 March 2007 annualised EPS of Rs 18.01.

The C&C Construction scrip had gained 11% in the one month to 28 June 2007 versus the Sensex's 0.65% rise. It added 20.82% in the past three months against Sensex's 10.96% rise.

The stock had hit a 52-week high of Rs 350 on 26 February 2007 and a 52-week low of Rs 158 on 8 March 2007.

The company's joint venture with B Seenaiah & Co. (Projects) has secured the contract. The project calls for development, design, construction, maintenance and operation of a 44-kilometre stretch of the highway from Kurali Kiratpur on national highway-21 connecting Chandigarh to the tourist and apple belt of Kullu Valley and beyond and other districts of Himachal Pradesh. The project will be on a build- operate-and-transfer basis.

The concession period is 20 years including construction period of two- and-a-half years.

C & C Constructions reported net profit of Rs 8.22 crore on sales of Rs 105.30 crore in Q3 March 2007.

C & C Constructions is an infrastructure project development company that provides engineering, procurement and construction services for infrastructure projects in India and Afghanistan.




No separation pangs for REI Agro

The scrip had touched a high of Rs 237.70, which is an all-time high for the counter. The scrip's low was Rs 204 during the day and closed at 219.05. The stock had hit a 52-week low of Rs 83 on 24 July 2006.

The stock had an average daily volume of 1.97 lakh shares on BSE in the past one quarter.

At the current price of Rs 218.45, the scrip trades at a PE multiple of 8.79, based on its Q3 December 2006 annualised EPS of Rs 24.85.

The REI Agro scrip had gained 6.19% in the one month to 26 June 2007 versus the Sensex's 0.65% rise. It added 4.79% in the past three months against the Sensex's 10.96% rise.

The company has set up a working committee to examine all the relevant issues relating to the proposed spin-off.

REI Agro’s net profit jumped 40% to Rs 25.30 crore in Q3 December 2006 as against Rs 18.01 crore in Q3 December 2005. Sales moved up 46.1% to Rs 240.73 crore in Q3 December 2006 (Rs 164.76 crore).

REI Agro's principal activity is to process and market of basmati rice. The company operates in two segments: rice and energy generation.



TVS Motor Company sputters on dismal Q4 results

The company declared the Q4 results after market hours yesterday, 28 June 2007.

The stock had an average daily volume of 2.56 lakh shares on BSE in the past one quarter.

At the current price of Rs 60.90, the scrip trades at a PE multiple of 21.78, based on its year ended March 2007 EPS of Rs 2.80.

The TVS Motor Company scrip had declined 3.15% in the one month to 26 June 2007 versus the Sensex's 0.65% rise. It added 8.31% in the past three months against the Sensex's 10.96% appreciation.

The stock had hit a 52-week high of Rs 129.70 on 3 October 2006 and a 52-week low of Rs 53.30 on 5 March 2007.

TVS Motors’ net profit slumped 68.89% to Rs 9.05 crore in Q4 March 2007 as against Rs 29.09 crore in the quarter ended March 2006. Sales moved up 9.60% to Rs 919.88 crore in Q4 March 2007 (Rs 839.27 crore).

Net profit dropped 43.08% to Rs 66.60 crore in the year ended March 2007 as against Rs 117.00 crore in FY 2006. Sales jumped 19.17% to Rs 3,854.96 crore in FY 2007 (Rs 3,234.96 crore).

The lower profit was on account of high cost of raw materials like steel, aluminium, rubber, copper, polymers.

The company’s exports rose 29% from 79,679 units in FY 2006 to 1,03,013 units in FY 2007.

TVS Motor Company manufactures and sells two-wheelers and components.




Sugar-complex plan stirs up GMR

The scrip had touched a high of Rs 170.35 and a low of Rs 167.40 during the day and closed at the day high of Rs 170.35. It had touched a 52-week high of Rs 378.60 on 28 November 2006 and a 52-week low of Rs 113.70 on 9 March 2007.

The average daily volume in the stock was 16,836 shares on BSE in the past one quarter.

The GMR Industries share had declined from Rs 143.95 on 6 June 2007 to Rs 131.6 on 19 June 2007. The stock had since then bounced back to Rs 162.25 on 28 June 2007.

The stock had advanced 18.91% in the past one month to 28 June 2007 versus the Sensex's 0.65% rise. It had outperformed the market in the past three months, rising 13.94% as against the Sensex's 10.96% appreciation.

The current price of Rs 170.35 discounts its FY 2007 EPS of Rs 10.7 by a PE multiple of 15.92.

GMR Industries has decided to set up an integrated sugar complex with a capacity of 2,500 tonnes per day (tcd), expandable to 3,500 tcd, in Srikakulam district, Andhra Pradesh. The company made the announcement during trading hours today, 29 June 2007.

The company's board also recommended a 15% dividend for the year ended March 2007.

GMR Industries reported a net loss of Rs 6.48 crore in Q4 March 2007 as against a net profit of Rs 4.87 crore in Q4 March 2006. Sales declined 27.9% to Rs 50.83 crore in Q4 March 2007 compared to Rs 70.51 crore in Q4 March 2006.

Net profit had surged 84.6% to Rs 34.52 crore in the year ended March 2007 (FY 2007) as against Rs 18.70 crore in FY 2006. Sales declined 13.9% to Rs256.36 crore in FY 2007 as against Rs 297.81 crore in FY 2006.

On 5 May 2007, GMR Industries said that the high court of Andhra Pradesh had sanctioned the scheme of arrangement of Bharat Sugar Mills and GMR Ferro Alloys & Industries. As per the scheme, the company will demerge its ferro alloys undertaking to GMR Ferro Alloys & Industries and amalgamate Bharat Sugar Mills with itself.

GMR Industries, the flagship GMR Group, operates mainly in two segments, metallurgical and sugar apart from international trade.




Kesoram Industries draws up capex plans and becomes a big draw

The scrip had touched a high of Rs 461 and a low of Rs 440 during the day and closed at Rs 453.35.

The stock had an average daily volume of 66,774 shares on BSE in the past one quarter.

At the current price of Rs 453.35, the scrip trades at a PE multiple of 7.78, based on year ended March 2007 EPS of Rs 58.3.

The Kesoram Industries scrip had gained 8.73% in the one month to 28 June 2007 versus the Sensex's 0.65% rise. It added 26.99% in the past three months against the Sensex's 10.96% appreciation.

The stock had hit a 52-week high of Rs 626.80 on 18 January 2007 and a 52-week low of Rs 200 on 28 June 2006.

On 28 June 2007 the scrip had risen 7.39% to Rs 435.50 on media reports that chairman Basant Kumar Birla has decided to give the diversified firm to his grandson Kumar Mangalam Birla, who heads the Aditya Birla group.

Kesoram Industries chairman Basant Kumar Birla told the media after the annual general meeting of Century Enka on Wednesday, 27 June 2007, that he would give all major companies of his group, including Kesoram Industries, to his grandson and Aditya Birla group chairman Kumar Mangalam Birla. Under the earlier succession plan, Kesoram was supposed to go to his younger daughter, Manjushree Khaitan.

It is believed that the change in the succession plan is due to synergies between the cement businesses of Kesoram and Kumar Mangalam’s companies Grasim and UltraTech Cement. Half of Kesoram’s revenue (Rs 1,156 crore) comes from cement, where the alignment with Kumar Mangalam's companies will make a big difference for the company.

Kesoram Industries’ net profit rose 188.3% to Rs 80.08 crore in Q4 March 2007 as against Rs 27.78 crore in Q4 March 2006. Sales moved up 45.5% to Rs 658.92 crore in Q4 March 2007 (Rs 452.96 crore).

Net profit scaled up 481.2% to Rs 265.68 crore in the year ended March 2007 as against Rs 45.71 crore in FY 2006. Sales jumped 36.6% to Rs 2,204.09 crore in FY 2007 (Rs 1,614.12 crore).

Kesoram Industries manufactures tyres, tubes, flaps, cement, viscose filament, rayon yarn, cellophane paper, sulphuric acid, caustic soda lye and hydrochloric acid.




Star Paper Mills is a star gainer ahead of hike in paper prices

The news hit the markets during trading hours today, 29 June 2007.

The scrip had touched a high of Rs 37.75 and a low of Rs 35.85 during the day and closed at 36.15.

The stock had average daily volume of 2,771 shares on BSE in the past one quarter.

At the current price of Rs 37.40, the scrip trades at a PE multiple of 9.46 based on its year ended March 2007 EPS of Rs 3.95.

The Star Paper Mills scrip had gained 3.43% in the one month to 28 June 2007 versus the Sensex's 0.65% rise. It added 5.79% in the past three months against the Sensex's 10.96% rise.

The stock had hit a 52-week high of Rs 51 on 9 October 2006 and a 52-week low of Rs 31 on 8 March 2007.

Star Paper Mills’ net profit soared 350% to Rs 2.52 crore in Q4 March 2007 as against Rs 0.56 crore in Q4 March 2006. Sales moved up 15.5% to Rs 57.22 crore in Q4 March 2007 (Rs 49.54 crore).

Net profit had fallen 33.6% to Rs 6.16 crore in the year ended March 2007 as against Rs 9.28 crore in FY 2006. Sales jumped 12.2% to Rs 210.85 crore in FY 2007 (Rs 187.91 crore).

The company manufactures paper products like writing and printing paper, paper boards and MG kraft paper. The products are marketed under the brand name Star.





US contract renewal tilts Suzlon Energy

The scrip had touched a high of Rs 1,525.50 and a low of Rs 1,474 during the and closed at Rs. 1493.55. It touched a 52-week high of Rs 1,555 on 27 June 2007 and a 52-week low of Rs 850 on 28 June 2006.

The average daily volume in the stock was 2.51 lakh shares on BSE in the past one quarter.

Suzlon Energy’s share price declined from Rs 1,374.20 on 7 June 2007 to Rs 1,294.05 on 13 June 2007. The stock had risen since then to Rs 1477.70 on 28 June 2007.

The stock had gained 15.15% in the past one month to 28 June 2007 versus the Sensex's 0.65% rise. It had outperformed the market in the past three months, rising 47.48% as against the Sensex's 10.96% appreciation.

The current price of Rs 1510.50 discounts its FY 2007 EPS of Rs 30.1(based on consolidated results) by a PE multiple of 50.18.

Suzlon Energy announced during market hours today, 29 June 2007, that its step-down subsidiary Suzlon Wind Energy Corporation, the US, had extended its contract with PPM Energy of Portland, Oregon, US, to add 300 mega watt (MW). The original agreement, calling for delivery of 300 MW of turbine capacity in 2008 and 100 MW of capacity in 2009, but now has been extended to include an additional 300 MW in 2009 for a total of 700 MW over two years.

Suzlon Energy’s net profit rose 21.56% to Rs 437.82 crore in Q4 March 2007 as against Rs 360.16 crore in Q4 March 2006. Sales were up 32.72% to Rs 2,055.48 crore in Q4 March 2007 as against Rs 1,548.71 crore in Q4 March 2006.

Net profit jumped 29.22% to Rs 1,061.14 crore in the year ended March 2007 (FY 2007) as against Rs 821.19 crore in FY 2006. Sales increased 42.02% to Rs 5,380.37 crore in FY 2007 as against Rs 3,788.46 crore in FY 2006.

In May 2007, Suzlon Energy had acquired German wind turbine manufacturer REpower after the French nuclear energy group Areva decided to withdraw from the bidding contest. REpower is one of Germany’s biggest wind-turbine makers and one of the world’s leading companies in wind energy sector.

Suzlon Energy's principal activities are to integrate consultancy, design, manufacturing, operation and maintenance services to provide customers with total wind power solutions.





Investors enter Lanxess ABS on en masse exit of promoters

The scrip had touched a high of Rs 211.35 today, which is a record high for the scrip. Its low was Rs 194.10 during the day Rs 205.55. It had touched a 52-week low Rs 102.40 on 24 July 2006.

The average daily volume in the stock was 12,117 shares on BSE in the past one quarter.

Lanxess ABS’s share price had declined from Rs 171.30 on 31 May 2007 to Rs 156.50 on 13 June 2007. The stock rose since then to Rs 192.15 on 28 June 2007.

The stock had gained 13.97% in the past one month to 28 June 2007 versus the Sensex's 0.65% rise. It had outperformed the market in the past three months, rising 36.66% as against the Sensex's 10.96% appreciation.

The current price of Rs 198 discounts its annualised Q1 March 2007 EPS of Rs 19 by a PE multiple of 10.42.

Lanxess ABS announced during market hours today, 29 June 2007, that the promoters of the company - Lanxess India, Rakesh Agrawal, Uma Agrawal, Rahul Agrawal, Vishal Agrawal, Geetganga Investments and Tash Investments - entered into an agreement on 28 June 2007 to sell their shares in the company to INEOS ABS (Jersey) a company controlled by the British chemical group INEOS. The parties expect the transaction to be completed at the end of September 2007.

Promoters hedld a 70% stake in the company (end March 2007).

Lanxess ABS's net profit doubled 100.69% to Rs 8.73 crore in Q1March 2007 as against Rs 4.35 crore in Q1 March 2006. Sales rose 41.30% to Rs 138.66 crore in Q1 March 2007 as against Rs 98.13 crore in Q1 March 2006.

Lanxess ABS is a Bayer group company manufacturing arylonitrile butadiene styrene (ABS) and styrene acrylonitrile (SAN) polymers. Earlier known as Bayer ABS, its name was changed to Lanxess ABS in 2004-05, according to the global restructuring of the Bayer group.

The company has its plants in Nandesari, Katol and Moxi in Gujarat. At its plant at Moxi in Gujarat, the company has also established a research & development (R&D) centre, which also caters to the needs of the global business.





IDBI advances on capital gains in NSE stake-sale

The announcement was made after trading hours yesterday, 28 June 2007.

The scrip had touched high of Rs 119.20 today ,which is its 52-week high. It touched a low of Rs 113.65 during the day and closed at Rs 118.65. The stock had hit a 52-week low of Rs 48.50 on 19 July 2006.

The stock had an average daily volume of 28.18 lakh shares on BSE in the past one quarter.

At the current price of Rs 117.20, the scrip trades at a PE multiple of 13.47, based on its year ended March 2007 EPS of Rs 8.70.

The IDBI scrip had gained 21.72% in the one month to 28 June 2007 versus the Sensex's 0.65% rise. It added 45.26% in the past three months against the Sensex's 10.96% appreciation.

Earlier in January 2007, the then NYSE Group Inc. and three others, including Goldman Sachs, each paid $115 million for a 5% stake each in the NSE.

Later in March 2007, the exchange said Morgan Stanley, Citigroup and private equity firm Actis had entered into agreements to buy stakes totaling 6% for undisclosed sums.

India caps foreign investment in its stock exchanges at 49%, including foreign direct investment of 26% and foreign portfolio investment of 23%. Any one strategic investor's stake is limited to 5%.

IDBI’s net profit rose 6.1% to Rs 213.54 crore in Q4 March 2007 as against Rs 201.24 crore in Q4 March 2006. Operating income moved up 12.4% to Rs 2,185.35 crore in Q4 March 2007 (Rs 1944.16 crore).

Net profit scaled up 12.4% to Rs 630.31 crore in the year ended March 2007 as against Rs 560.89 crore in FY 2006. Sales jumped 10.7% to Rs 7,372.60 crore in FY 2007 (Rs 6,661.17 crore).

State-run IDBI provides commercial banking services, which include merchant banking, direct finance, infrastructure finance, rehabilitation assistance, venture capital fund, advisory, trusteeship, forex, treasury and other related financial services.




Sun TV shines bright on strong Q4 results

The results were announced after market hours on Thursday 28 June 2007.

The scrip had touched a high of Rs 1,641 and a low of Rs 1,545 during the day and closed at Rs 1,595.10 . Its 52-week high was Rs 1,849 on 8 February 2007 and 52-week low Rs 950 on 28 June 2006.

The average daily volume in the stock was 28,210 shares on BSE in the past one quarter.

Sun TV Network’s share price rose from Rs 1,322.15 on 8 June 2007 to Rs 1,620.85 on 26 June 2007. The stock had declined since then to Rs 1,527.35 on 28 June 2007.

The stock had gained 9.14% in the past one month to 28 June 2007 versus the Sensex's 0.65% rise. It had underperformed the market in the past three months, rising 0.96% as against the Sensex's 10.96% appreciation.

The current price of Rs 1610 discounts its FY 2007 EPS of Rs 39.02 by a PE multiple of 41.26.

Sun TV Network’s net profit surged 310.9% to Rs 118.86 crore in Q4 March 2007 as compared to Rs 28.93 crore in Q4 March 2006. Sales spurted 382.2% to Rs379.04 crore in Q4 March 2007 as against Rs 78.60 crore in Q4 March 2007.

Net profit jumped 106.42% to Rs 268.82 crore in the year ended March 2007 (FY 2007) as against Rs 130.23 crore in FY 2006. Sales advanced 110.29% to Rs 676.95 crore in FY 2007 as against Rs 321.91 crore in FY 2006.

Along with the Q4 results, Sun TV Network also informed stock exchanges that the register of members & share transfer books will remain closed from 28 July 2007 to 6 August 2007 (both days inclusive) for the purpose of payment of final dividend, stock split, bonus issue.

The company had earlier announced a stock split from face value of Rs10 each to face value of Rs5 each and bonus in the ratio of one equity share of Rs 5 each for every share held. Thus bonus will be issued after giving effect to the stock-split.

Sun TV announced on 14 June 2007 it signed an exclusive cable and satellite channels agreement with Nimbus Communications to broadcast live feed of the one day international (ODI) matches of the Ireland Series between India, Ireland, South Africa and Pakistan, to be held between on 23 June 2007 to 3 July 2007.

The company launched its FM Radio Station in Bhubaneshwar under the brand 'S FM' from June 28, 2007 through its subsidiary South Asia FM .

Sun TV's integrated growth strategy is to build a dominant presence in south India. It is a leading television broadcaster in all southern states of India. It offers four Tamil language channels including Sun TV, Sun News, Sun Music and KTV as also two Malayalam channels Surya TV and Kiran TV, apart from Telugu and Kannada channels.

Sun TV also operates leading Tamil radio stations, Suryan FM in Chennai, Coimbatore and Tirunelveli. The two subsidiaries of the company, Kal Radio and South Asia FM, jointly hold 41 FM radio licences for FM radio stations across India.




Wheels turn for Wendt India on change of driver

The company made the announcement before trading hours today, 29 June 2007.

The scrip had touched a high of Rs 797.75 and a low of Rs 785 during the day and closed at day high of Rs 797.75.

The stock had average daily volume of 376 shares on BSE in the past one quarter.

At the current price of Rs 790, the scrip trades at a PE multiple of 18.14, based on the year ended March 2007 EPS of Rs 43.55.

The Wendt India scrip had gained 3.16% in the one month to 26 June 2007 versus the Sensex's 0.65% rise. It added 13.91% in the past three months against the Sensex's 10.96% return.

The stock had hit a 52-week high of Rs 872 on 24 August 2006 and a 52-week low of Rs 551.30 on 27 July 2006.

Wendt GmbH has sold its entire stake to Winterthur Technologie. Earlier this year, Winterthur, the industrial grinding-wheels maker, had said it would buy Germany's Wendt Holding for 99 million euros.

Wendt India’s net profit rose 22.2% to Rs 2.37 crore in Q4 March 2007 as against Rs 1.94 crore in Q4 March 2006. Sales moved up 13.8% to Rs 13.92 crore in Q4 March 2007 (Rs 12.23 crore).

Net profit scaled up 21.6% to Rs 8.71 crore in the year ended March 2007 as against Rs 7.16 crore in FY 2006. Sales jumped 21.9% to Rs 50.74 crore in FY 2007 (Rs 41.63 crore).

Wendt manufactures super-abrasive grinding wheels and tools. Its products are used in automobile, cutting too, engineering, steel, tile, ferrite, glass, ceramics and watch industries.




Investors hunt with Infosys on the prowl

The scrip had touched a high of Rs 1,975 and a low of Rs 1,922 during the day and closed at Rs 1929.20. Its 52-week high was Rs 2,439 on 19 February 2007 and 52-week low Rs 1440 on 28 June 2006.

The average daily volume in the stock was 3.14 lakh shares on BSE in the past one quarter.

The Infosys Technologies’ share price had risen from Rs ,1916.45 on 4 June 207 to Rs 2,000.10 on 15 June 2007. The stock had declined since then to Rs 1,925.90 on 28 June 2007.

The scrip had gained 1.13% in the past one month to 27 June 2007 versus the Sensex's 0.65% rise. It had underperformed the market in the past three months, declining 4.31% as against the Sensex's 10.96% appreciation.

The current price of Rs 1,951.50 discounts its FY 2007 EPS of Rs 67.3(based on the consolidated financial performance) by a PE multiple of 28.99.

Both Infosys Technologies and Capgemini have denied the takeover rumours, though the Capgemini stock surged on Thursday, 28 June 2007, boosted by this rumour.

Infosys Technologies' net profit soared 69.28 % to Rs 1,124 crore in Q4 March 2007 as against Rs 664 crore in Q4 March 2006. Net sales grew 42.60 % to Rs 3555 crore in Q4 March 2007 as against Rs 2493 crore in Q4 March 2006.

The company registered a growth of 56.26% in net profit to Rs 3,783 crore in the year ended March 2007 (FY 2007) as against Rs. 2421 crore in FY 2006. Net sales grew 45.65% to Rs 13,149 crore in FY 2007 as against Rs 9,028 crore in FY 2006.

Infosys Technologies will announce its first quarter June 2007 results on 11 July 2007.